| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.59B | +4.9% | +14.9% |
| Cost of Revenue | $685.0M | +7.4% | +14.3% |
| Gross Profit | $1.91B | +4.0% | +15.1% |
| R&D Expense | $511.0M | -3.2% | +1.0% |
| SG&A Expense | $178.0M | -0.6% | +15.7% |
| Operating Income | $397.0M | +28.5% | +65.1% |
| Pre-tax Income | $549.0M | +33.3% | +69.0% |
| Income Tax | $117.0M | +50.0% | +103.5% |
| Net Income | $432.0M | +29.3% | +61.6% |
| EPS (Basic) | $0.61 | +24.5% | +48.8% |
| EPS (Diluted) | $0.61 | +29.8% | +60.5% |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.16B | +35.6% | +86.8% |
| Short-term Investments | $378.0M | -67.0% | -62.4% |
| Accounts Receivable | $2.12B | +57.6% | +41.5% |
| Current Assets | $8.37B | +14.5% | +32.0% |
| Total Assets | $24.98B | +6.1% | +19.2% |
| Current Liabilities | $8.01B |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $2.33B | +31.3% | — |
| Investing Cash Flow | -$332.0M | +66.2% | — |
| Financing Cash Flow | -$106.0M | -1425.0% | — |
| +6.0% |
| Total Liabilities | $15.59B | +4.8% | +6.9% |
| Stockholders' Equity | $9.39B | +8.4% | +47.3% |